Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents
about
SUSCEPTIBILITY TEST FOR FUNGI: CLINICAL AND LABORATORIAL CORRELATIONS IN MEDICAL MYCOLOGYAntifungal susceptibilities of Candida isolates causing bloodstream infections at a medical center in Taiwan, 2009-2010Screening for drug-resistant Candida yeasts with chromogenic agar.Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemiaA novel flucytosine-resistant yeast species, Candida pseudoaaseri, causes disease in a cancer patientMulticenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp.Resistance patterns and clinical significance of Candida colonization and infection in combat-related injured patients from iraq and afghanistan.Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden.Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.Clinical and economic outcomes of decreased fluconazole susceptibility in patients with Candida glabrata bloodstream infections.Detection of amphotericin B resistance in Candida haemulonii and closely related species by use of the Etest, Vitek-2 yeast susceptibility system, and CLSI and EUCAST broth microdilution methodsThe presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata.Detection of caspofungin resistance in Candida spp. by Etest.Clonal population of flucytosine-resistant Candida tropicalis from blood cultures, Paris, FranceCaspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposureAntifungal activity of caspofungin in combination with amphotericin B against Candida glabrata: comparison of disk diffusion, Etest, and time-kill methodsBreakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata.Trends in antifungal susceptibility testing using CLSI reference and commercial methods.Candida tropicalis in human disease.ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia.Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.Antifungal susceptibility of bloodstream Candida isolates in Sfax hospital: Tunisia.Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin.Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification.Synergistic activities of three triazoles with caspofungin against Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods.Antifungal Activity of Ellagic Acid In Vitro and In Vivo.Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric Sensititre YeastOne mComparison of 24-hour and 48-hour voriconazole MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) in three laboratories: results obtained with 2,162 clinical isolates of Candida spp. anEchinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots.Epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole for six Candida species as determined by the colorimetric Sensititre YeastOne methodComparison of anidulafungin MICs determined by the clinical and laboratory standards institute broth microdilution method (M27-A3 document) and Etest for Candida species isolates.Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive Candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods.Antifungal susceptibility of clinical Candida parapsilosis isolates in Kuwait.Antifungal susceptibility in vitro determined by the Etest® for Candida obtained from the oral cavity of irradiated and elderly individuals.Comparison of commercial methods and the CLSI broth microdilution to determine the antifungal susceptibility of Candida parapsilosis complex bloodstream isolates from three health institutions in Rio de Janeiro, Brazil.Evaluation of direct antifungal susceptibility testing methods of Candida spp. from positive blood culture bottles.Evaluation of antifungal susceptibility testing with microdilution and Etest methods of Candida blood isolates.Species distribution and in vitro antifungal susceptibility of clinical Candida isolates from a university hospital in Turkey over a 5-year period.In vitro susceptibility of Candida species to four antifungal agents assessed by the reference broth microdilution method.
P2860
Q26783197-359C030C-A72A-44C4-A8AA-427919031DB7Q33798413-C9129FA3-E3E3-408D-A38A-9CAAB71BAFD5Q34009338-DB543D89-F6EA-4F58-9370-3C0BA6DDFA16Q34022724-D149B780-9335-4E86-B878-7B936105B094Q34041471-967BB43E-FD2D-4AD0-9967-8EC8945B9D90Q35066649-936A399C-FDCF-4D79-B1D1-C080EEEED216Q35072030-A95E5C4A-FEC9-4E42-90E4-BEEBC8D374B0Q35140020-3E3F84E6-41D8-40FF-A765-3FD21F0C4E62Q35487439-AA305185-2C72-4460-90E7-9EF20C6F1ACBQ35558411-2B487048-398F-4A08-9D2D-A8DEF651FF9CQ36022880-D23F2F65-C4C3-4604-86A9-56D1C56C2FB0Q36172500-A6AA7C8D-21A7-4C6B-9358-563EC22C1B4CQ36747567-05FE49F2-EDB3-4473-A93B-7DA7B15771B6Q36944929-AF6205D3-794A-4250-A004-F78F94DEF7D4Q37036603-E767F5BB-8A77-43F0-8DC2-F4D91FC67397Q37072012-45E98CD8-4E68-46B5-B52E-8490968C9078Q37115801-ABADF310-679A-4751-8C9C-7A795B253D09Q37214044-FDF3A98D-0253-454A-839D-103D2A04A8F8Q37557695-CEBF8E3C-4418-469C-AA9A-BF7803CC445FQ37794979-DD5B677E-FD84-405D-A039-BE63125EB855Q37974519-9A68CFE9-CE33-452D-BE7E-563A9E2C0C5BQ39092240-5D762E16-EF0C-450C-A85C-8DBCCACB156FQ39445046-1308169A-E298-464A-96B7-9A8C65507697Q39763435-9ED5F8A1-51E8-4E34-BE87-891361D12107Q40045673-2B2FBB26-4A64-42BF-AA37-735BA6936269Q40337564-855B9DBE-CA1C-4C3D-AD55-65031573AD77Q41278850-75F99EE9-8048-4BAC-87FD-56A63B900CB2Q41640129-38921A1A-98FB-49E3-B350-F1DD7F71A79EQ42025836-603EC9B7-FDF8-4F19-989D-F2B143607A20Q42706331-B6C48E8F-4FCF-4CD0-90B6-F504BE5BFD7DQ42710734-B054EC0E-F0D3-449F-8FBC-2BDC6140083CQ42910172-8D77B6D5-A2D1-4E49-8270-8723246FCB7DQ42929602-D63CFADE-284C-45D0-BADA-5E6649FD44ACQ44503190-5707F3F1-8459-44DB-8DA8-D13B7E203898Q46750212-87E1946E-64DB-45C2-B7D6-449A9C803DB4Q46876146-9ABD3345-3677-4DBD-B88B-99EDA2D4E952Q48133554-0D290A41-2A9B-4D9B-BD7A-BB42494DA60BQ51175703-16E120C4-FF44-4289-B9DF-8A9DF517B346Q51755610-16E3BA8E-3436-4363-A71B-9B92E2140EDAQ54574311-DDC8822D-845B-4D9C-A15D-82426D7D4B10
P2860
Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Comparative evaluation of Etes ...... ity to seven antifungal agents
@ast
Comparative evaluation of Etes ...... ity to seven antifungal agents
@en
type
label
Comparative evaluation of Etes ...... ity to seven antifungal agents
@ast
Comparative evaluation of Etes ...... ity to seven antifungal agents
@en
prefLabel
Comparative evaluation of Etes ...... ity to seven antifungal agents
@ast
Comparative evaluation of Etes ...... ity to seven antifungal agents
@en
P2093
P2860
P356
P1476
Comparative evaluation of Etes ...... ity to seven antifungal agents
@en
P2093
Barbara D Alexander
Kelly L Smith
Kimberly E Hanson
L Barth Reller
Terry C Byrne
P2860
P304
P356
10.1128/JCM.01840-06
P407
P577
2007-01-03T00:00:00Z